ERNA vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 10, 2026

ERNA

41.1
AI Score
VS
CLYM Wins

CLYM

50.9
AI Score

Investment Advisor Scores

ERNA

41score
Recommendation
HOLD

CLYM

51score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ERNA CLYM Winner
Net Income -7.29M -27.22M ERNA
Operating Income -7.25M -30.57M ERNA
ROE -95.2% -11.4% CLYM
ROA -56.5% -11.1% CLYM
Total Assets 12.91M 246.29M CLYM
Cash 777,000 44.11M CLYM
Current Ratio 0.55 31.45 CLYM
Free Cash Flow -8.14M -25.18M ERNA

Relative Price Performance (Last 90 Days)

ERNA 1M: -5.8% · 3M: -36.5% CLYM 1M: -1.0% · 3M: +30.6%

Current Technical Phase

ERNA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -16.2%), weak momentum, RSI 42

RSI (14): 42.3 · Price: $4.17

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 46

RSI (14): 45.8 · Price: $14.25

Fundamentals Snapshot

Metric ERNA CLYM
Market Cap
Forward P/E -2.2 -14.2
Trailing P/E
Revenue (TTM)
Revenue Growth -0.9% 0.0%
Gross Margin 1.0%
Operating Margin 0.0% 0.0%
EPS -0.41 -0.82
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, CLYM is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.